JP2008523130A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523130A5
JP2008523130A5 JP2007545917A JP2007545917A JP2008523130A5 JP 2008523130 A5 JP2008523130 A5 JP 2008523130A5 JP 2007545917 A JP2007545917 A JP 2007545917A JP 2007545917 A JP2007545917 A JP 2007545917A JP 2008523130 A5 JP2008523130 A5 JP 2008523130A5
Authority
JP
Japan
Prior art keywords
mmol
thf
phenyl
solvent
reduced pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007545917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008523130A (ja
Filing date
Publication date
Priority claimed from GBGB0427381.9A external-priority patent/GB0427381D0/en
Application filed filed Critical
Publication of JP2008523130A publication Critical patent/JP2008523130A/ja
Publication of JP2008523130A5 publication Critical patent/JP2008523130A5/ja
Pending legal-status Critical Current

Links

JP2007545917A 2004-12-14 2005-12-12 Crth2受容体アンタゴニスト活性を有するピロール誘導体 Pending JP2008523130A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427381.9A GB0427381D0 (en) 2004-12-14 2004-12-14 Organic compounds
PCT/EP2005/013297 WO2006063763A1 (en) 2004-12-14 2005-12-12 Pyrrole derivatives having crth2 receptor antagonist activity

Publications (2)

Publication Number Publication Date
JP2008523130A JP2008523130A (ja) 2008-07-03
JP2008523130A5 true JP2008523130A5 (enExample) 2009-02-05

Family

ID=34090028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007545917A Pending JP2008523130A (ja) 2004-12-14 2005-12-12 Crth2受容体アンタゴニスト活性を有するピロール誘導体

Country Status (21)

Country Link
US (1) US20100087432A1 (enExample)
EP (1) EP1828172B1 (enExample)
JP (1) JP2008523130A (enExample)
KR (1) KR20070087605A (enExample)
CN (1) CN101072773B (enExample)
AR (1) AR052266A1 (enExample)
AT (1) ATE449772T1 (enExample)
AU (1) AU2005315881C1 (enExample)
BR (1) BRPI0518607A2 (enExample)
CA (1) CA2587934A1 (enExample)
DE (1) DE602005017935D1 (enExample)
ES (1) ES2335519T3 (enExample)
GB (1) GB0427381D0 (enExample)
GT (1) GT200500360A (enExample)
MX (1) MX2007007098A (enExample)
PE (1) PE20060736A1 (enExample)
PL (1) PL1828172T3 (enExample)
PT (1) PT1828172E (enExample)
RU (1) RU2007126761A (enExample)
TW (1) TW200635921A (enExample)
WO (1) WO2006063763A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0611695D0 (en) * 2006-06-13 2006-07-26 Novartis Ag Organic compounds
TW200848019A (en) * 2007-03-06 2008-12-16 Wyeth Corp Aryl sulfonamides useful for modulation of the progesterone receptor
ATE502920T1 (de) 2007-12-14 2011-04-15 Pulmagen Therapeutics Asthma Ltd Indole und ihre therapeutische verwendung
BRPI1008906B1 (pt) * 2009-02-24 2019-10-15 Merck Sharp & Dohme Corp. Composto, composição farmacêutica, e, uso de um composto
CN102822163B (zh) 2009-12-23 2016-01-20 艾恩伍德医药品股份有限公司 Crth2调节剂
SI2558447T1 (sl) 2010-03-22 2015-01-30 Actelion Pharmaceuticals Ltd. Derivati 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-karbazola in njihova uporaba kot modulatorji prostaglandinskega receptorja d2
WO2011117184A1 (de) 2010-03-24 2011-09-29 Bayer Cropscience Ag Fludioxonil-derivate
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
WO2012078210A1 (en) * 2010-12-08 2012-06-14 Ironwood Pharmaceuticals, Inc. Crth2 modulators and preparation thereof
EP2697223B1 (en) 2011-04-14 2016-07-13 Actelion Pharmaceuticals Ltd. 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
JP2015500326A (ja) 2011-12-16 2015-01-05 アトピックス テラピューティクス リミテッド 好酸球性食道炎の治療のためのcrth2拮抗薬およびプロトンポンプ阻害薬の組み合わせ
EP2794563B1 (en) 2011-12-21 2017-02-22 Actelion Pharmaceuticals Ltd Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
US20150080381A1 (en) * 2012-04-12 2015-03-19 Ironwood Pharmaceuticals, Inc. Methods of treating alopecia and acne
WO2014006585A1 (en) 2012-07-05 2014-01-09 Actelion Pharmaceuticals Ltd 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
ES2461415B1 (es) * 2012-10-16 2015-03-16 Consejo Superior De Investigaciones Científicas (Csic) Derivados funcionalizados e inmunorreactivos para el fungicida fludioxonil
CN103553990B (zh) * 2013-11-08 2016-01-20 苏州诚和医药化学有限公司 用卤素卤化合成2-甲氧基-4-氨基-5-乙砜基苯甲酸甲酯的方法
CN103588686B (zh) * 2013-11-08 2016-01-20 苏州诚和医药化学有限公司 一种用卤素卤化制备2-甲氧基-4-氨基-5-乙砜基苯甲酸甲酯的方法
CN103553991B (zh) * 2013-11-08 2016-01-20 苏州诚和医药化学有限公司 一种制备2-甲氧基-4-氨基-5-乙砜基苯甲酸甲酯的方法
HRP20181555T1 (hr) 2014-03-17 2018-11-30 Idorsia Pharmaceuticals Ltd Derivati azaindol-octene kiseline i njihova uporaba kao modulatora receptora prostaglandina d2
EP3119780B1 (en) 2014-03-18 2018-08-29 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
EA035752B1 (ru) 2015-09-15 2020-08-05 Идорсиа Фармасьютиклз Лтд КРИСТАЛЛИЧЕСКАЯ ФОРМА (S)-2-(8-((5-ХЛОРПИРИМИДИН-2-ИЛ)(МЕТИЛ)-АМИНО)-2-ФТОР-6,7,8,9-ТЕТРАГИДРО-5Н-ПИРИДО[3,2-b]ИНДОЛ-5-ИЛ)УКСУСНОЙ КИСЛОТЫ И СОДЕРЖАЩИЕ ЕЁ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
CN108164502B (zh) * 2018-03-06 2021-04-13 苏州华一新能源科技有限公司 1,3-丙烷磺酸内酯的制备方法
CN112602714B (zh) * 2020-12-23 2021-11-16 华南农业大学 一类咯菌腈羧酸衍生物在用于植物维管组织靶向药剂中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182737A3 (de) * 1984-10-16 1986-10-08 Ciba-Geigy Ag 3-Phenylpyrrolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0386681A1 (de) * 1989-03-08 1990-09-12 Ciba-Geigy Ag 3-Aryl-4-cyano-pyrrol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende mikrobiozide Mittel
JP4316232B2 (ja) * 2001-12-28 2009-08-19 武田薬品工業株式会社 アンドロゲン受容体拮抗剤
AU2002367424A1 (en) * 2001-12-28 2003-07-24 Takeda Chemical Industries, Ltd. Androgen receptor antagonists
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
CA2568742A1 (en) * 2004-05-29 2005-12-08 7Tm Pharma A/S Substituted thiazoleacetic as crth2 ligands

Similar Documents

Publication Publication Date Title
JP2008523130A5 (enExample)
Buechi et al. Nitro olefination of indoles and some substituted benzenes with 1-dimethylamino-2-nitroethylene
JP2009525279A5 (enExample)
CN110337434B (zh) 制备2-氰基咪唑化合物的方法
JP2013515755A5 (enExample)
TW201725208A (zh) 1,3-苯并二氧雜環戊烯雜環化合物之製備方法
WO2023134677A1 (zh) 制备吡咯化合物的方法及其中间体
Ambethkar et al. Iodine-mediated C–N and C–S bond formation: regioselective synthesis of benzo [4, 5] imidazo [2, 1-b] thiazoles
CA2278687C (en) 5-aroylnaphthalene derivatives
Lucarini et al. Organocatalyzed coupling of indoles with dehydroalanine esters: synthesis of bis (indolyl) propanoates and indolacrylates
WO2022111564A1 (zh) 一种吡啶衍生物的消旋方法及应用
CN115010707B (zh) 喹啉并吡咯衍生物的制备方法
CN109134875B (zh) L-薄荷醇为手性源的手性共价有机骨架材料的制备
CN106380440B (zh) 一种茚酮并吡咯类衍生物及其合成方法和应用
Kim et al. Efficient syntheses of 2-carbomethoxy-3, 4-disubstituted pyrroles by the condensation of vinylogous amides with aminomalonate
Demircan et al. A FACILE SYNTHESIS OF HETEROTRICYCLES FROM FURFURYLBROMOALKENES USING THERMAL IMDA CYCLO ADDITION
Boshta et al. Synthesis of 2, 2-functionalized benzo [1, 3] dioxoles
Rajanarendar et al. A fast and highly efficient protocol for synthesis of pyrrolo [2, 3-d] isoxazoles and a new series of novel benzyl bis-pyrrolo [2, 3-d] isoxazoles using task-specific ionic liquids as catalyst and green solvent
CN105585540A (zh) 一种新型Swern试剂的制备与应用
JP2009256298A (ja) ピペリジン−3−イルカーバメート化合物の光学分割方法およびその中間体
CN106496097B (zh) 一种3-溴-9-(9-苯基芴-9-基)咔唑的合成方法
Gérard et al. Direct synthesis of new arylanthranilic acids via a Suzuki cross-coupling reaction from iodoisatins
CN109020860B (zh) 一种2-芳基-3-酯基多取代吡咯类化合物及其合成精制方法
CN106117247B (zh) 一种2‑甲基‑1,2,3,9‑四氢苯并[b]吡咯[1,4]‑噻嗪‑1,3‑二酮类化合物的制备方法
Aiello et al. Efficient synthesis of 9H-pyrrolo [1, 2-a] indol-9-one derivatives based on active manganese dioxide promoted intramolecular cyclization